Friday, March 6, 2026
7:30 AM - 8:30 AM
7:30 AM - 8:30 AM
Breakfast
8:30 AM - 8:50 AM
8:30 AM - 8:50 AM
Welcome & Opening Remarks
8:50 AM - 9:10 AM
8:50 AM - 9:10 AM
Delphi Framework and Objectives
9:10 AM - 9:30 AM
9:10 AM - 9:30 AM
Integrating Innovation and Evidence in Liver Transplantation
9:30 AM - 10:00 AM
9:30 AM - 10:00 AM
Coffee Break
10:00 AM - 12:30 PM
10:00 AM - 12:30 PM
Hepatocellular Carcinoma: Harmonizing trial endpoints and eligibility
10:00 AM - 12:30 PM
Alcohol-Related Liver Disease: Ethical trial frameworks for early LT and relapse
10:00 AM - 12:30 PM
Machine Perfusion: Trial structures and endpoints for perfusion
12:30 PM - 1:30 PM
12:30 PM - 1:30 PM
Sponsored Lunch Symposium
1:30 PM - 3:30 PM
1:30 PM - 3:30 PM
Alcohol-Related Liver Disease: Biomarkers for relapse risk and injury differentiation
1:30 PM - 3:30 PM
Hepatocellular Carcinoma: Biomarker pipelines for clinical qualification
1:30 PM - 3:30 PM
Machine Perfusion: Predictive biomarkers of graft function
4:00 PM - 5:30 PM
4:00 PM - 5:30 PM
Alcohol-Related Liver Disease: AI to improve relapse prediction & ethical monitoring
4:00 PM - 5:30 PM
Machine Perfusion: AI for decision support in perfusion
4:00 PM - 5:30 PM
Hepatocellular Carcinoma: AI for recurrence prediction and imaging
5:30 PM - 6:00 PM
5:30 PM - 6:00 PM
Summary of Key Recommendations
6:30 PM - 8:00 PM
6:30 PM - 8:00 PM
Dinner
Saturday, March 7, 2026
7:45 AM - 8:15 AM
7:45 AM - 8:15 AM
Sponsored Networking Breakfast
8:15 AM - 9:30 AM
8:15 AM - 9:30 AM
ALD: Integrating Biomarkers & AI into Ethical ALD Trials
8:15 AM - 9:30 AM
Innovation in Focus
8:15 AM - 9:30 AM
HCC: Precision Trials and Biomarker Validation in Transplant Oncology
8:15 AM - 9:30 AM
MP: Clinical Trial Design & Real-Time Biomarkers
9:30 AM - 12:45 PM
9:30 AM - 12:45 PM

From Evidence to Consensus: Unified Standards for Trials, Biomarkers & AI

12:45 PM - 1:00 PM
12:45 PM - 1:00 PM

Group Photo

Time Zone: (UTC-05:00) Eastern Time (US & Canada) [Change Time Zone]